Commercial monovalent antivenoms in Australia are polyvalent

Toxicon

Volumn 54, Issue 2, 2009, Pages 192-195

  O'Leary, Margaret A ^a   Isbister, Geoffrey K ^a,b,c  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Antivenom; Cross neutralisation; Envenoming; Snake bite; Venom

Indexed keywords

SNAKE VENOM; SNAKE VENOM ANTISERUM; SPIDER VENOM ANTISERUM;

ARTICLE; AUSTRALIA; BINDING AFFINITY; DRUG BINDING; DRUG MANUFACTURE; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; SNAKEBITE;

ANIMALS; BOTHROPS; HUMANS; INFLAMMATION; METALLOPROTEASES; PAIN; PHOSPHOLIPASES A2; SERINE ENDOPEPTIDASES; VIPER VENOMS;

ELAPIDAE; EQUIDAE; LATRODECTUS HASSELTI; NOTECHIS SCUTATUS; PSEUDONAJA TEXTILIS; SPILOTES PULLATUS PULLATUS; STORERIA DEKAYI;

EID: 65749099588     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.04.004     Document Type: Article

References (4)

1. Isbister G.K., Brown S.G., MacDonald E., White J., and Currie B.J. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med. J. Aust 188 (2008) 473-476
2. O'Leary M.A., Isbister G.K., Schneider J.J., Brown S.G., and Currie B.J. Enzyme immunoassays in brown snake (Pseudonaja spp.) envenoming: Detecting venom, antivenom and venom-antivenom complexes. Toxicon 48 (2006) 4-11
3. O'Leary M.A., Schneider J.J., Krishnan B.P., Lavis C., McKendry A., Ong L.K., et al. Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?. Toxicon 50 (2007) 206-213
4. White J. CSL Antivenom Handbook (2001), CSL Ltd, Melbourne